ExAdEx-Innov Wins Descroix-Vernier EthicScience 2025 Award
ExAdEx-Innov has been awarded the prestigious Descroix-Vernier EthicScience 2025 Award in the « Prix du Jury – Espoir de la Recherche » category for its work in developing adipose tissue models for obesity research. This award, the only one in France dedicated to non-animal research and supported by Fondation Descroix-Vernier and Comité Scientifique Pro Anima recognizes […]
ExAdEx-Innov to Present Novel 3D Vascularized Organoid Research at COMET Congress
ExAdEx-Innov is set to showcase its most recent dermo-cosmetic research on its proprietary 3D vascularized adult tissue models at COMET Congress 2025 The COMET Congress, the scientific congress dedicated to cosmetic measurement and testing, is back in January 2025! Our presentation will highlight our most recent development of 3D imaging techniques and 4D imaging analysis […]
ExAdEx Technology Contributes to the Development of VividEye™
ExAdEx-Innov Drives Innovation in Cosmetic Industry: Contributing to the Development of VividEye™ from Mibelle Biochemistry We are thrilled to announce ExAdEx-Innov’s contribution to the research and development of VividEye™, a new cosmetic product recently launched by Mibelle Biochemistry. This contribution showcases our commitment to driving innovation across industries and demonstrates the power of our ExAdEx […]
Integrating 2D human stem cell model to enlarge R&D platform tools
ExAdEx-Innov announces the signature of a licence agreement with CNRS Innovation on human stem cell model to enlarge R&D platform tools from cells to tissue With the aim of integrating complementary models to its proprietary platform and strengthening the panel of research and development projects covered, ExAdEx-Innov has signed a licence agreement with CNRS Innovation […]
Exsymol partners with ExAdEx-Innov to explore new avenues of adipose tissue research
ExAdEx-Innov and Exsymol Monaco are proud to announce their collaboration for innovative cosmetic research. Exsymol is a leader in the conception of active ingredients for cosmetics and nutrition for more than 45 years, including Silanols, Exsymol’s signature technology: a unique and innovative family of cosmetic actives with a heart of organic silicium. The collaboration between […]
ExAdEx-Innov selected for Nice Côte d’Azur Metropolis Acceleration Program
ExAdEx-Innov has been selected among the 12 winners that will join the acceleration program for high-potential local businesses initiated by Nice Côte d’Azur Metropolis, in partnership with the INTERFACES-POST ADVISORS Group. Fully funded by the Metropolis, this program offers personalized support over a six-month period to boost local businesses in key sectors such as Health, […]
Exclusive sub-licence agreement with SATT Sud-Est
ExAdEx-Innov announces the entry of SATT Sud-Est into its capital and the signing of an exclusive license agreement.
Joining La French Tech Côte d’Azur
Happy to join the French Tech mission and the big family of the regional team La French Tech Côte d’Azur, a unique association gathering entrepreneurs, startups and investors to boost the development and growth of French innovative and deeptech companies! Facebook Twitter LinkedIn Latest News Our News Archives
Proudly joining Réseau Entreprendre Côte d’Azur
Our co-founders Vincent Dani and Luigi Formicola are glad and proud to join Réseau Entreprendre Côte d’Azur, a local network of entrepreneurs committed to develop local businesses and startups and support newly incorporated companies through mentoring and funding. That’s a great acknowledgement for ExAdEx-Innov startup project and a big booster for our development! Facebook Twitter […]
Our ObAdEx biotherapy project labeled by Eurobiomed
ObAdEx, our innovative biotherapy product in development for chronic metabolic diseases associated to obesity, gets labelled by Eurobiomed, the healthtech growth accelerator of South of France. Eurobiomed highlights our breakthrough and innovative approach as well as our tailored preclinical developmental plan to de-risk critical bioproduction steps before first-in-patients trials. ExAdEx-Innov is currently leading a fundraising […]